We serve Chemical Name:ethyl 2-chloro-2-methylsulfanylacetate CAS:56078-31-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:ethyl 2-chloro-2-methylsulfanylacetate
CAS.NO:56078-31-0
Synonyms:ethyl 2-chloro-2-methylthio-acetate
Molecular Formula:C5H9ClO2S
Molecular Weight:168.64200
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:51.60000
Exact Mass:168.00100
LogP:1.47740
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like ethyl 2-chloro-2-methylthio-acetate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,ethyl 2-chloro-2-methylthio-acetate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,ethyl 2-chloro-2-methylthio-acetate Use and application,ethyl 2-chloro-2-methylthio-acetate technical grade,usp/ep/jp grade.
Related News: GEM has also partnered with Good360 & Walmart to ensure that every relocated family has move in essentials like bedding, towels, small appliances, tableware, cutlery, glassware and cookware. In addition, each relocated family in the program will receive our GEM Bstrong, Good360, and Walmart ‘Welcome Home Kits’ consisting of new sheets, towels, silverware, pots and pans sets, small appliances and basic move in goods. Transportation of goods provided by GEM transportation partner UC Group (www.groupncs.com). ethyl (R)-2-((5,6-dichloro-9a-ethyl-3-oxo-2,3,9,9a-tetrahydro-1H-fluoren-7-yl)oxy)acetate manufacturers After a four-year battle over a cancer drug patent, Novartis has been ordered by a California judge to pay a Daiichi Sankyo subsidiary $177.8 million. N-(4-Chloro-phenyl)-2-[1-(3-nitro-phenyl)-meth-(E)-ylidene]-3-oxo-butyramide suppliers Plexxikon filed a lawsuit against the pharma giant in 2017, alledging that Tafinlar, a rival to its melanoma drug Zelboraf that was brought to market in collaboration with Roche, has stepped on its intellectual property. The jury ruled in its favor, adding that the infringement is in fact willful. Morpholine, 4-[[5-(chloromethyl)-1,3,4-oxadiazol-2-yl]methyl]- vendor & factory.
